Subject: Changes in senior management

Management Changes:

  • Dr Prabhakar Chebiyyam, President, Pharmaceuticals, has retired from the company.
  • Dr Dhaval Vashi has taken over charge as Senior Vice President, Pharmaceuticals, and became a member of the senior management team effective July 18, 2026, replacing Dr Chebiyyam.
  • Mr Vinay Desai, Executive Vice President, Technology and Manufacturing, has become a member of the senior management team effective July 18, 2026.

Executive Profiles:

Dr Dhaval Vashi

  • Associated with the Company since December 2022
  • Approximately 22 years of experience in Business Development
  • Holds postgraduate degree in science (organic chemistry)
  • Holds doctorate degree in synthetic organic chemistry

Mr Vinay Desai

  • Associated with the Company since December 2022
  • Approximately 35 years of experience in manufacturing and technology development
  • Holds graduate degree in chemical engineering

The disclosure was made to BSE Limited (Scrip code: 500027, Symbol: ATUL) and National Stock Exchange of India Limited through their respective electronic filing systems on July 20, 2026.